mRNA Synthesis & Manufacturing Market by Product (Consumables (Transcription, Purification, Analysis & Characterization), Instrument), Service (Synthesis, Purification, Manufacturing & Scale-up), Application (CGT, Vaccines) - Global Forecast to 2029

icon1
USD 2.96 BN
MARKET SIZE, 2029
icon2
CAGR 5.8%
(2024-2029)
icon3
340
REPORT PAGES
icon4
470
MARKET TABLES

OVERVIEW

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The mRNA synthesis and manufacturing market is projected to reach USD 2.96 billion by 2029 from USD 2.23 billion in 2024, at a CAGR of 5.8% from 2024 to 2029. The market growth is fueled by rising demand in clinical trials for mRNA vaccines, along with the increased outsourcing of mRNA synthesis and production.

KEY TAKEAWAYS

  • The North America mRNA synthesis & manufacturing market accounted for a 47.1% revenue share in 2024.
  • By product, the instruments segment is expected to register the highest CAGR of 5.8%
  • By service, the mRNA synthesis & modification services segment is expected to register the highest CAGR of 7.6%
  • By application, the cell & gene therapies segment is projected to grow at the fastest rate from 2024 to 2029.
  • By end user (product), the pharmaceutical & biotechnology companies segment is expected to dominate the market.
  • By end user (services), the pharmaceutical & biotechnology companies segment is expected to dominate the market.
  • Company Danaher Corporation, Thermo Fisher Scientific Inc. and Merck KGaA were identified as some of the star players in the mRNA synthesis & manufacturing market (global), given their strong market share and product footprint.
  • Companies etherna, Biomay AG and Jena Bioscience GmbH, among others, have distinguished themselves among startups and SMEs by securing strong footholds in specialized niche areas, underscoring their potential as emerging market leaders

The mRNA synthesis & manufacturing market is projected to grow rapidly over the next decade, supported by improvements in design, delivery systems, and manufacturing processes. The growth is primarily driven by the increasing demand for mRNA vaccines and the growing demand for personalized medicines, as well as the advantages of mRNA-based technology over recombinant expression.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

The mRNA synthesis and manufacturing market is undergoing rapid transformation driven by new use cases, technologies, and ecosystem collaborations. Future revenue growth will primarily stem from scalable GMP-grade production, improved mRNA stability, and cost-efficient workflows. Pharmaceutical & biotechnology companies, academic institutions, and CROs & CDMOs are prioritizing automation, digital integration, and process optimization to enhance therapeutic efficacy, accelerate vaccine and drug development, and achieve faster regulatory approvals through robust, compliant, and flexible manufacturing platforms.

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • Rise in clinical trials for mRNA vaccines
  • Continuous improvements in design, delivery systems, and manufacturing processes
RESTRAINTS
Impact
Level
  • High production cost
  • Stringent regulations
OPPORTUNITIES
Impact
Level
  • Ongoing innovations in nanoparticles and cell- specific delivery technologies
  • Expanding applications of mRNA technology
CHALLENGES
Impact
Level
  • Stability, storage, and manufacturing scalability issues

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Rise in clinical trials for mRNA vaccines

The rising number of clinical trials for mRNA vaccines is a significant growth driver for the mRNA synthesis and manufacturing market. Increased trial activity fuels demand for high-quality mRNA production, formulation, and scaling capabilities. This surge in research and development accelerates investments in manufacturing infrastructure, driving revenue growth for service providers and technology suppliers across the mRNA ecosystem.

Restraint: High production cost

High production costs remain a key restraint for the mRNA synthesis and manufacturing market. The complex processes, specialized equipment, and stringent quality requirements significantly increase operational expenses. These elevated costs can limit adoption, slow scale-up efforts, and restrict entry for smaller players, thereby constraining overall market growth despite rising demand for mRNA-based therapeutics and vaccines.

Opportunity: Ongoing innovations in nanoparticles and cell- specific delivery technologies

Innovations in nanoparticles and cell-specific delivery technologies are advancing the mRNA synthesis and manufacturing market. These technologies improve the stability, precision, and effectiveness of mRNA therapeutics and vaccines, enabling the development of targeted treatments. As a result, manufacturers can expand their capabilities and offerings, supporting broader adoption and growth within the market.

Challenge: Stability, storage, and manufacturing scalability issues

Stability, storage, and manufacturing scalability issues pose significant challenges for the mRNA synthesis and manufacturing market. mRNA molecules are inherently unstable and require stringent cold-chain storage, while scaling up production remains complex and resource-intensive. These factors increase operational costs, limit distribution efficiency, and can slow the adoption of mRNA therapeutics and vaccines, thereby constraining overall market growth.

mRNA Synthesis & Manufacturing Market: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
Partnered with Lonza to scale the rapid manufacturing of its mRNA-1273 COVID-Ig vaccine (IVT mRNA production, LNP formulation, and commercial fill/finish) Rapid scale-up | diversified global manufacturing footprint | risk reduction through multi-partner supply chain
Built a network of COMO partners across Europe for each key manufacturing step (IW reaction, downstream processing, formulation, fill/finish) of their vaccine candidate CVnCoV |Included technology transfers to partners so multiple sites could produce intermediate or finished products Achieved scale-up of production capacity more quickly | reduced dependency on a single site | improved resilience to the supply chain or logistics disruptions

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The mRNA synthesis and manufacturing market ecosystem consists of raw material suppliers (3M, BASF), mRNA product suppliers (Thermo Fisher Scientific Inc., New England Biolabs), mRNA service providers (Merck KGaA, Lonza), regulatory bodies (US Food and Drug Administration, European Medicines Agency), and end users (Moderna, Inc., Massachusetts Institute of Technology). Raw materials, including nucleotides, enzymes, and plasmid DNA templates, are processed into high-quality mRNA products for vaccines and therapeutics. End users drive demand for efficacy, stability, and targeted delivery, while manufacturers provide scalable, precision-controlled synthesis and formulation. Collaboration across the value chain is crucial for innovation, enhanced delivery technologies, and overall market growth.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

mRNA Synthesis and Manufacturing Market, By Product

In 2023, consumables segment dominated the mRNA synthesis and manufacturing market driven by the expanding applications of mRNA technology, scaling production needs, and ongoing innovation.

mRNA Synthesis and Manufacturing Market, By Application

In 2023, the vaccines segment dominated the mRNA synthesis and manufacturing market, driven by the ongoing development and expansion of mRNA-based vaccines for a wide range of infectious diseases beyond COVID-19, which necessitate advanced synthesis and manufacturing capabilities.

mRNA Synthesis and Manufacturing Market, By Service

In 2023, the mRNA synthesis & modification segment accounted for the largest share of the mRNA synthesis and manufacturing market. This can be attributed to the rising mRNA synthesis at a large scale. As the application of mRNA technology expands, researchers and developers increasingly seek tailored mRNA sequences that can be optimized for specific therapeutic outcomes, such as improved protein expression or enhanced immune response.

REGION

Asia Pacific to be fastest-growing region in global mRNA synthesis and manufacturing market during forecast period

The Asia Pacific mRNA synthesis and manufacturing market is expected to register the highest CAGR during the forecast period, driven by various factors, including rising healthcare expenditure, growing R&D expansion in key markets such as India, China, and Japan, as well as low labor costs. Additionally, the favorable regulatory environment in the region is expected to contribute to market growth.

mRNA Synthesis & Manufacturing Market: COMPANY EVALUATION MATRIX

Merck KGaA (Star) leads the mRNA synthesis and manufacturing market with a strong market share and an extensive product portfolio, driven by its high-quality mRNA platforms, reagents, and scalable manufacturing solutions, which are widely adopted across vaccine and therapeutic development. Sartorius AG (Emerging Leader) is gaining visibility with its advanced bioprocessing technologies, modular systems, and tailored solutions for mRNA production, strengthening its position through innovation and niche offerings. While Merck dominates through scale and a diverse portfolio, Sartorius shows significant potential to move toward the leaders’ quadrant as demand for efficient, scalable, and high-quality mRNA manufacturing continues to rise.

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

MARKET SCOPE

REPORT METRIC DETAILS
Market Size in 2023 (Value) USD 2.22 Billion
Market Forecast in 2029 (Value) USD 2.96 Billion
Growth Rate CAGR of 5.8% from 2024-2029
Years Considered 2022-2029
Base Year 2023
Forecast Period 2024-2029
Units Considered Value (USD Billion)
Report Coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments Covered
  • By Product: Consumables and Instruments
  • By Application:
    • Cell & Gene Therapies
    • Vaccines
    • and Other Applications
  • By Service:
    • mRNA synthesis & modification services
    • mRNA purification services
    • mRNA analysis & characterization services
    • and manufacturing & scale-up services
  • By End User (Product) :
    • Pharmaceutical & Biotechnology Companies
    • Academic & Research Institutes
    • and CROs & CDMOs
  • By End User (Service) :
    • Pharmaceutical & Biotechnology Companies
    • Academic & Research Institutes
    • and Small-Scale CROs & CDMOs
Regions Covered North America, Asia Pacific, Europe, Latin America, Middle East & Africa

WHAT IS IN IT FOR YOU: mRNA Synthesis & Manufacturing Market REPORT CONTENT GUIDE

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST CUSTOMIZATION DELIVERED VALUE ADDS
Asia Pacific Market breakdown
  • Country-level market sizing and growth forecasts (India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Vietnam, Philippines)
  • Segmentation by consumables and instruments
 Provides granular country-level insights, enabling clients to prioritize high-growth markets, optimize resource allocation, and tailor portfolio strategies across consumables and instruments for maximum regional impact
Company Evaluation
  • Detailed analysis and profiling of top three marekt players
  • Competitive benchmarking of CDMOs specializing in mRNA synthesis and formulation
 Delivers visibility into competitors and CDMOs, helping clients identify partners, evaluate positioning, and detect market gaps for smarter collaboration, outsourcing, and strategic market entry decisions

RECENT DEVELOPMENTS

  • May 2024 : GenScript launched a self-amplifying RNA synthesis service for advanced therapeutic applications. These enhance the potency and efficacy of vaccines, immunotherapies, and gene therapies.
  • July 2024 : Merck KGaA entered into an agreement with Afrigen Biologics on the set-up and development of an mRNA vaccine technology platform.
  • July 2024 : Merck KGaA started commercial production of its first Good Manufacturing Practices (GMP) compliant manufacturing line for cell culture media (CCM) in China.
  • May 2024 : TriLink BioTechnologies collaborated with Johns Hopkins University to establish a new RNA Innovation Center.

 

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
1
INTRODUCTION
 
 
 
32
2
RESEARCH METHODOLOGY
 
 
 
36
3
EXECUTIVE SUMMARY
 
 
 
49
4
PREMIUM INSIGHTS
 
 
 
54
5
MARKET OVERVIEW
mRNA market growth fueled by clinical trials, technological advances, and increased funding despite high costs.
 
 
 
56
 
5.1
INTRODUCTION
 
 
 
 
5.2
MARKET DYNAMICS
 
 
 
 
 
5.2.1
DRIVERS
 
 
 
 
 
5.2.1.1
RISE IN CLINICAL TRIALS FOR MRNA VACCINES
 
 
 
 
5.2.1.2
CONTINUOUS IMPROVEMENTS IN DESIGN, DELIVERY SYSTEMS, AND MANUFACTURING PROCESSES
 
 
 
 
5.2.1.3
INCREASED OUTSOURCING OF MRNA SYNTHESIS AND PRODUCTION
 
 
 
 
5.2.1.4
ADVANTAGES OF MRNA-BASED TECHNOLOGY OVER RECOMBINANT EXPRESSION
 
 
 
5.2.2
RESTRAINTS
 
 
 
 
 
5.2.2.1
HIGH PRODUCTION COST
 
 
 
 
5.2.2.2
STRINGENT REGULATIONS
 
 
 
5.2.3
OPPORTUNITIES
 
 
 
 
 
5.2.3.1
ONGOING INNOVATIONS IN NANOPARTICLES AND CELL-SPECIFIC DELIVERY TECHNOLOGIES
 
 
 
 
5.2.3.2
EXPANDING APPLICATIONS OF MRNA TECHNOLOGY
 
 
 
 
5.2.3.3
INCREASED GOVERNMENT FUNDING AND PRIVATE INVESTMENTS
 
 
 
5.2.4
CHALLENGES
 
 
 
 
 
5.2.4.1
STABILITY, STORAGE, AND MANUFACTURING SCALABILITY ISSUES
 
 
5.3
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
 
 
 
 
5.4
REGULATORY LANDSCAPE
 
 
 
 
 
5.4.1
REGULATORY FRAMEWORK
 
 
 
 
5.4.2
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
5.5
VALUE CHAIN ANALYSIS
 
 
 
 
 
5.6
TECHNOLOGY ANALYSIS
 
 
 
 
 
5.6.1
KEY TECHNOLOGIES
 
 
 
 
 
5.6.1.1
IN VITRO TRANSCRIPTION
 
 
 
 
5.6.1.2
POLY(A) TAIL SYNTHESIS
 
 
 
 
5.6.1.3
RNA STABILIZATION TECHNOLOGIES
 
 
 
5.6.2
COMPLEMENTARY TECHNOLOGIES
 
 
 
 
 
5.6.2.1
NEXT-GENERATION SEQUENCING
 
 
 
 
5.6.2.2
GENE CLONING AND VECTOR CONSTRUCTION
 
 
 
 
5.6.2.3
DNA AMPLIFICATION
 
 
 
5.6.3
ADJACENT TECHNOLOGIES
 
 
 
 
 
5.6.3.1
SPECTROPHOTOMETRY
 
 
 
 
5.6.3.2
ELECTROPHORESIS
 
 
 
 
5.6.3.3
HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY
 
 
5.7
PRICING ANALYSIS
 
 
 
 
 
 
5.7.1
AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY INSTRUMENT
 
 
 
 
5.7.2
AVERAGE SELLING PRICE TREND FOR CONSUMABLES
 
 
 
 
5.7.3
AVERAGE SELLING PRICE, BY REGION
 
 
 
5.8
PATENT ANALYSIS
 
 
 
 
 
5.9
SUPPLY CHAIN ANALYSIS
 
 
 
 
 
5.10
ECOSYSTEM ANALYSIS
 
 
 
 
 
5.11
KEY CONFERENCES AND EVENTS, 2025–2026
 
 
 
 
5.12
PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
5.12.1
INTENSITY OF COMPETITIVE RIVALRY
 
 
 
 
5.12.2
BARGAINING POWER OF SUPPLIERS
 
 
 
 
5.12.3
BARGAINING POWER OF BUYERS
 
 
 
 
5.12.4
THREAT OF SUBSTITUTES
 
 
 
 
5.12.5
THREAT OF NEW ENTRANTS
 
 
 
5.13
KEY STAKEHOLDERS AND BUYING CRITERIA
 
 
 
 
 
 
5.13.1
KEY STAKEHOLDERS IN BUYING PROCESS
 
 
 
 
5.13.2
KEY BUYING CRITERIA, BY END USER (PRODUCT)
 
 
 
5.14
INVESTMENT AND FUNDING SCENARIO
 
 
 
 
5.15
IMPACT OF AI ON MRNA SYNTHESIS & MANUFACTURING MARKET
 
 
 
 
6
MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT
Market Size & Growth Rate Forecast Analysis to 2029 in USD Million | 90 Data Tables
 
 
 
90
 
6.1
INTRODUCTION
 
 
 
 
6.2
CONSUMABLES
 
 
 
 
 
6.2.1
TRANSCRIPTION CONSUMABLES
 
 
 
 
 
6.2.1.1
MRNA SYNTHESIS KITS
 
 
 
 
6.2.1.2
MRNA PROFILING KITS
 
 
 
 
6.2.1.3
RNA POLYMERASES
 
 
 
 
6.2.1.4
PLASMID DNA/DNA TEMPLATES
 
 
 
 
6.2.1.5
NUCLEOTIDES
 
 
 
 
6.2.1.6
VECTORS
 
 
 
 
6.2.1.7
OTHER TRANSCRIPTION CONSUMABLES
 
 
 
6.2.2
PURIFICATION CONSUMABLES
 
 
 
 
 
6.2.2.1
PURIFICATION KITS & REAGENTS
 
 
 
 
6.2.2.2
CHROMATOGRAPHY FILTERS & MEMBRANES
 
 
 
 
6.2.2.3
OTHER PURIFICATION CONSUMABLES
 
 
 
6.2.3
ANALYSIS & CHARACTERIZATION CONSUMABLES
 
 
 
 
 
6.2.3.1
ANALYSIS KITS & REAGENTS
 
 
 
 
6.2.3.2
OTHER ANALYSIS & CHARACTERIZATION CONSUMABLES
 
 
6.3
INSTRUMENTS
 
 
 
 
 
6.3.1
NEED TO REDUCE PRODUCTION COST AND HIGHER SCALABILITY TO PROMOTE GROWTH
 
 
7
MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION
Market Size & Growth Rate Forecast Analysis to 2029 in USD Million | 16 Data Tables
 
 
 
129
 
7.1
INTRODUCTION
 
 
 
 
7.2
CELL & GENE THERAPIES
 
 
 
 
 
7.2.1
RISING ADOPTION OF MRNA TECHNOLOGY TO TREAT GENETIC DISORDERS AND CANCER TO FUEL MARKET
 
 
 
7.3
VACCINES
 
 
 
 
 
7.3.1
INCREASING DEVELOPMENT AND DEPLOYMENT OF MRNA VACCINES TO ACCELERATE GROWTH
 
 
 
7.4
OTHER APPLICATIONS
 
 
 
8
MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2029 in USD Million | 16 Data Tables
 
 
 
137
 
8.1
INTRODUCTION
 
 
 
 
8.2
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
 
 
 
 
 
8.2.1
NEED TO RESPOND TO EMERGING INFECTIOUS DISEASES TO DRIVE MARKET
 
 
 
8.3
ACADEMIC & RESEARCH INSTITUTIONS
 
 
 
 
 
8.3.1
INCREASING INVESTMENTS IN RESEARCH TO EXPEDITE GROWTH
 
 
 
8.4
CROS & CDMOS
 
 
 
 
 
8.4.1
RISING DEMAND FOR OUTSOURCED SERVICES TO AID GROWTH
 
 
9
MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE
Market Size & Growth Rate Forecast Analysis to 2029 in USD Million | 21 Data Tables
 
 
 
146
 
9.1
INTRODUCTION
 
 
 
 
9.2
MRNA SYNTHESIS & MODIFICATION SERVICES
 
 
 
 
 
9.2.1
GROWING NEED FOR CUSTOMIZED MRNA SEQUENCES AND MODIFICATIONS TO FUEL MARKET
 
 
 
9.3
MRNA PURIFICATION SERVICES
 
 
 
 
 
9.3.1
NEED FOR PERSONALIZED MRNA VACCINES TO BOOST MARKET
 
 
 
9.4
MRNA ANALYSIS & CHARACTERIZATION SERVICES
 
 
 
 
 
9.4.1
INCREASING REGULATORY SCRUTINY TO EXPEDITE GROWTH
 
 
 
9.5
MANUFACTURING & SCALE-UP SERVICES
 
 
 
 
 
9.5.1
GROWING TRANSITION FROM SMALL-SCALE RESEARCH & DEVELOPMENT TO LARGE-SCALE COMMERCIAL PRODUCTION TO DRIVE MARKET
 
 
10
MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2029 in USD Million | 16 Data Tables
 
 
 
156
 
10.1
INTRODUCTION
 
 
 
 
10.2
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
 
 
 
 
 
10.2.1
RAPID DEVELOPMENT AND COMMERCIALIZATION OF MRNA-BASED PRODUCTS TO ENCOURAGE GROWTH
 
 
 
10.3
ACADEMIC & RESEARCH INSTITUTIONS
 
 
 
 
 
10.3.1
INCREASING EMPHASIS ON TRANSLATING MRNA-BASED DISCOVERIES INTO PRACTICAL APPLICATIONS TO AID GROWTH
 
 
 
10.4
SMALL-SCALE CROS & CDMOS
 
 
 
 
 
10.4.1
NEED FOR SPECIALIZED AND FLEXIBLE PRODUCTION IN BIOTECH COMPANIES AND EARLY-STAGE MRNA PROJECTS TO BOOST MARKET
 
 
11
MRNA SYNTHESIS & MANUFACTURING MARKET, BY REGION
Comprehensive coverage of 6 Regions with country-level deep-dive of 12 Countries | 214 Data Tables.
 
 
 
165
 
11.1
INTRODUCTION
 
 
 
 
11.2
NORTH AMERICA
 
 
 
 
 
11.2.1
MACROECONOMIC OUTLOOK FOR NORTH AMERICA
 
 
 
 
11.2.2
US
 
 
 
 
 
11.2.2.1
INCREASING DEMAND FOR MRNA-BASED VACCINES AND THERAPEUTICS TO ACCELERATE GROWTH
 
 
 
11.2.3
CANADA
 
 
 
 
 
11.2.3.1
INCREASING COLLABORATIONS BETWEEN ACADEMIC INSTITUTIONS AND MARKET PLAYERS TO SPUR GROWTH
 
 
11.3
EUROPE
 
 
 
 
 
11.3.1
MACROECONOMIC OUTLOOK FOR EUROPE
 
 
 
 
11.3.2
GERMANY
 
 
 
 
 
11.3.2.1
GROWING ESTABLISHMENT OF MANUFACTURING SITES TO BOOST MARKET
 
 
 
11.3.3
UK
 
 
 
 
 
11.3.3.1
PRESENCE OF STATE-OF-THE-ART FACILITIES TO SUPPORT GROWTH
 
 
 
11.3.4
FRANCE
 
 
 
 
 
11.3.4.1
FAVORABLE GOVERNMENT SUPPORT FOR BIOPHARMACEUTICAL PRODUCTION TO DRIVE MARKET
 
 
 
11.3.5
SWITZERLAND
 
 
 
 
 
11.3.5.1
ROBUST BIOTECH SECTOR AND PRODUCTION FACILITIES TO PROMOTE GROWTH
 
 
 
11.3.6
ITALY
 
 
 
 
 
11.3.6.1
INCREASING COLLABORATIONS AMONG BIOTECH FIRMS AND MANUFACTURING FACILITIES TO AID GROWTH
 
 
 
11.3.7
SPAIN
 
 
 
 
 
11.3.7.1
GROWING INVESTMENTS IN BIOTECHNOLOGY TO FUEL MARKET
 
 
 
11.3.8
REST OF EUROPE
 
 
 
11.4
ASIA PACIFIC
 
 
 
 
 
11.4.1
MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
 
 
 
 
11.4.2
CHINA
 
 
 
 
 
11.4.2.1
RAPID EXPANSION OF DOMESTIC BIOTECH SECTOR TO CONTRIBUTE TO GROWTH
 
 
 
11.4.3
JAPAN
 
 
 
 
 
11.4.3.1
GROWING STRATEGIC INVESTMENTS IN BIOTECHNOLOGY INFRASTRUCTURE TO BOOST MARKET
 
 
 
11.4.4
INDIA
 
 
 
 
 
11.4.4.1
BOOMING BIOTECH SECTOR AND INTERNATIONAL COLLABORATIONS TO AUGMENT GROWTH
 
 
 
11.4.5
SOUTH KOREA
 
 
 
 
 
11.4.5.1
INCREASED GOVERNMENT FUNDING IN RESEARCH AND VACCINE DEVELOPMENT TO BOLSTER GROWTH
 
 
 
11.4.6
REST OF ASIA PACIFIC
 
 
 
11.5
LATIN AMERICA
 
 
 
 
 
11.5.1
MACROECONOMIC OUTLOOK FOR LATIN AMERICA
 
 
 
 
11.5.2
BRAZIL
 
 
 
 
 
11.5.2.1
INCREASED FUNDING FOR STRENGTHENING INFRASTRUCTURE TO SUSTAIN GROWTH
 
 
 
11.5.3
REST OF LATIN AMERICA
 
 
 
11.6
MIDDLE EAST
 
 
 
 
 
11.6.1
GROWING INVESTMENTS FROM PRIVATE SECTOR AND ACADEMIC RESEARCH INITIATIVES TO DRIVE MARKET
 
 
 
 
11.6.2
MACROECONOMIC OUTLOOK IN MIDDLE EAST
 
 
 
11.7
AFRICA
 
 
 
 
 
11.7.1
GROWING INITIATIVES TO ENHANCE LOCAL PRODUCTION CAPABILITIES TO PROPEL MARKET
 
 
 
 
11.7.2
MACROECONOMIC OUTLOOK FOR AFRICA
 
 
13
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
 
 
 
277
 
13.1
KEY PLAYERS
 
 
 
 
 
13.1.1
THERMO FISHER SCIENTIFIC INC.
 
 
 
 
 
13.1.1.1
BUSINESS OVERVIEW
 
 
 
 
13.1.1.2
PRODUCTS/SERVICES OFFERED
 
 
 
 
13.1.1.3
RECENT DEVELOPMENTS
 
 
 
 
13.1.1.4
MNM VIEW
 
 
 
13.1.2
DANAHER CORPORATION
 
 
 
 
13.1.3
MERCK KGAA
 
 
 
 
13.1.4
LONZA
 
 
 
 
13.1.5
MARVAI LIFESCIENCES
 
 
 
 
13.1.6
GENSCRIPT
 
 
 
 
13.1.7
NEW ENGLAND BIOLABS
 
 
 
 
13.1.8
PROMEGA CORPORATION
 
 
 
 
13.1.9
WUXI BIOLOGICS
 
 
 
 
13.1.10
TAKARA BIO INC.
 
 
 
 
13.1.11
SARTORIUS AG
 
 
 
 
13.1.12
AZENTA US INC.
 
 
 
 
13.1.13
TELESIS BIO INC.
 
 
 
 
13.1.14
ST PHARM
 
 
 
 
13.1.15
AGC INC. (THROUGH AGC BIOLOGICS)
 
 
 
 
13.1.16
DR. REDDY’S LABORATORIES LTD.
 
 
 
13.2
OTHER PLAYERS
 
 
 
 
 
13.2.1
ETHERNA
 
 
 
 
13.2.2
BOC SCIENCES
 
 
 
 
13.2.3
BIOMAY AG
 
 
 
 
13.2.4
CURIA GLOBAL, INC.
 
 
 
 
13.2.5
JENA BIOSCIENCE GMBH
 
 
 
 
13.2.6
ENZYNOMICS CO., LTD.
 
 
 
 
13.2.7
KANEKA EUROGENTEC S.A.
 
 
 
 
13.2.8
VERNAL BIOSCIENCES
 
 
 
 
13.2.9
CELLSCRIPT
 
 
14
APPENDIX
 
 
 
343
 
14.1
DISCUSSION GUIDE
 
 
 
 
14.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
 
 
 
 
14.3
CUSTOMIZATION OPTIONS
 
 
 
 
14.4
RELATED REPORTS
 
 
 
 
14.5
AUTHOR DETAILS
 
 
 
LIST OF TABLES
 
 
 
 
 
TABLE 1
MRNA SYNTHESIS & MANUFACTURING MARKET: INCLUSIONS AND EXCLUSIONS
 
 
 
 
TABLE 2
IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
 
 
 
 
TABLE 3
MRNA SYNTHESIS & MANUFACTURING MARKET: RISK ANALYSIS
 
 
 
 
TABLE 4
MRNA SYNTHESIS & MANUFACTURING MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS
 
 
 
 
TABLE 5
INDICATIVE LIST OF MRNA VACCINES IN CLINICAL TRIALS (AS OF DECEMBER 2024)
 
 
 
 
TABLE 6
INDICATIVE LIST OF MRNA-BASED DRUGS IN CLINICAL TRIALS (AS OF DECEMBER 2024)
 
 
 
 
TABLE 7
REGULATORY FRAMEWORK FOR MRNA SYNTHESIS & MANUFACTURING MARKET WORLDWIDE
 
 
 
 
TABLE 8
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 9
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 10
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 11
REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 12
AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY INSTRUMENT, 2021–2023 (USD)
 
 
 
 
TABLE 13
AVERAGE SELLING PRICE TREND FOR CONSUMABLES, 2021–2023 (USD)
 
 
 
 
TABLE 14
AVERAGE SELLING PRICE, BY REGION, 2023 (USD)
 
 
 
 
TABLE 15
MRNA SYNTHESIS & MANUFACTURING MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2021–2024
 
 
 
 
TABLE 16
MRNA SYNTHESIS & MANUFACTURING MARKET: ROLE OF COMPANIES IN ECOSYSTEM
 
 
 
 
TABLE 17
MRNA SYNTHESIS & MANUFACTURING MARKET: KEY CONFERENCES AND EVENTS, 2025–2026
 
 
 
 
TABLE 18
MRNA SYNTHESIS & MANUFACTURING MARKET: IMPACT OF PORTER’S FIVE FORCES
 
 
 
 
TABLE 19
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING (%)
 
 
 
 
TABLE 20
KEY BUYING CRITERIA, BY PRODUCT END USER
 
 
 
 
TABLE 21
MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 22
MRNA SYNTHESIS & MANUFACTURING CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 23
NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 24
EUROPE: MRNA SYNTHESIS & MANUFACTURING CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 25
ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 26
LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 27
MRNA SYNTHESIS & MANUFACTURING CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 28
TRANSCRIPTION CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 29
TRANSCRIPTION CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 30
NORTH AMERICA: TRANSCRIPTION CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 31
EUROPE: TRANSCRIPTION CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 32
ASIA PACIFIC: TRANSCRIPTION CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 33
LATIN AMERICA: TRANSCRIPTION CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 34
MRNA SYNTHESIS KITS MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 35
NORTH AMERICA: MRNA SYNTHESIS KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 36
EUROPE: MRNA SYNTHESIS KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 37
ASIA PACIFIC: MRNA SYNTHESIS KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 38
LATIN AMERICA: MRNA SYNTHESIS KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 39
MRNA PROFILING KITS MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 40
NORTH AMERICA: MRNA PROFILING KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 41
EUROPE: MRNA PROFILING KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 42
ASIA PACIFIC: MRNA PROFILING KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 43
LATIN AMERICA: MRNA PROFILING KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 44
RNA POLYMERASES MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 45
NORTH AMERICA: RNA POLYMERASES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 46
EUROPE: RNA POLYMERASES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 47
ASIA PACIFIC: RNA POLYMERASES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 48
LATIN AMERICA: RNA POLYMERASES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 49
PLASMID DNA/DNA TEMPLATES MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 50
NORTH AMERICA: PLASMID DNA/DNA TEMPLATES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 51
EUROPE: PLASMID DNA/DNA TEMPLATES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 52
ASIA PACIFIC: PLASMID DNA/DNA TEMPLATES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 53
LATIN AMERICA: PLASMID DNA/DNA TEMPLATES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 54
NUCLEOTIDES MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 55
NORTH AMERICA: NUCLEOTIDES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 56
EUROPE: NUCLEOTIDES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 57
ASIA PACIFIC: NUCLEOTIDES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 58
LATIN AMERICA: NUCLEOTIDES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 59
VECTORS MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 60
NORTH AMERICA: VECTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 61
EUROPE: VECTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 62
ASIA PACIFIC: VECTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 63
LATIN AMERICA: VECTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 64
OTHER TRANSCRIPTION CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 65
NORTH AMERICA: OTHER TRANSCRIPTION CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 66
EUROPE: OTHER TRANSCRIPTION CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 67
ASIA PACIFIC: OTHER TRANSCRIPTION CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 68
LATIN AMERICA: OTHER TRANSCRIPTION CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 69
PURIFICATION CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 70
PURIFICATION CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 71
NORTH AMERICA: PURIFICATION CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 72
EUROPE: PURIFICATION CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 73
ASIA PACIFIC: PURIFICATION CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 74
LATIN AMERICA: PURIFICATION CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 75
PURIFICATION KITS & REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 76
NORTH AMERICA: PURIFICATION KITS & REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 77
EUROPE: PURIFICATION KITS & REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 78
ASIA PACIFIC: PURIFICATION KITS & REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 79
LATIN AMERICA: PURIFICATION KITS & REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 80
CHROMATOGRAPHY FILTERS & MEMBRANES MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 81
NORTH AMERICA: CHROMATOGRAPHY FILTERS & MEMBRANES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 82
EUROPE: CHROMATOGRAPHY FILTERS & MEMBRANES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 83
ASIA PACIFIC: CHROMATOGRAPHY FILTERS & MEMBRANES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 84
LATIN AMERICA: CHROMATOGRAPHY FILTERS & MEMBRANES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 85
OTHER PURIFICATION CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 86
NORTH AMERICA: OTHER PURIFICATION CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 87
EUROPE: OTHER PURIFICATION CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 88
ASIA PACIFIC: OTHER PURIFICATION CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 89
LATIN AMERICA: OTHER PURIFICATION CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 90
ANALYSIS & CHARACTERIZATION CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 91
ANALYSIS & CHARACTERIZATION CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 92
NORTH AMERICA: ANALYSIS & CHARACTERIZATION CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 93
EUROPE: ANALYSIS & CHARACTERIZATION CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 94
ASIA PACIFIC: ANALYSIS & CHARACTERIZATION CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 95
LATIN AMERICA: ANALYSIS & CHARACTERIZATION CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 96
ANALYSIS KITS & REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 97
NORTH AMERICA: ANALYSIS KITS & REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 98
EUROPE: ANALYSIS KITS & REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 99
ASIA PACIFIC: ANALYSIS KITS & REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 100
LATIN AMERICA: ANALYSIS KITS & REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 101
OTHER ANALYSIS & CHARACTERIZATION CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 102
NORTH AMERICA: OTHER ANALYSIS & CHARACTERIZATION CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 103
EUROPE: OTHER ANALYSIS & CHARACTERIZATION CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 104
ASIA PACIFIC: OTHER ANALYSIS & CHARACTERIZATION CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 105
LATIN AMERICA: OTHER ANALYSIS & CHARACTERIZATION CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 106
MRNA SYNTHESIS & MANUFACTURING INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 107
NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 108
EUROPE: MRNA SYNTHESIS & MANUFACTURING INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 109
ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 110
LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 111
MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 112
MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR CELL & GENE THERAPIES, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 113
NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR CELL & GENE THERAPIES, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 114
EUROPE: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR CELL & GENE THERAPIES, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 115
ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR CELL & GENE THERAPIES, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 116
LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR CELL & GENE THERAPIES, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 117
MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR VACCINES, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 118
NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR VACCINES, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 119
EUROPE: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR VACCINES, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 120
ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR VACCINES, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 121
LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR VACCINES, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 122
MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 123
NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 124
EUROPE: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 125
ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 126
LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 127
MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 128
MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 129
NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 130
EUROPE: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 131
ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 132
LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 133
MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 134
NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 135
EUROPE: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 136
ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 137
LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 138
MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR CROS & CDMOS, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 139
NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR CROS & CDMOS, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 140
EUROPE: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR CROS & CDMOS, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 141
ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR CROS & CDMOS, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 142
LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR CROS & CDMOS, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 143
MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 144
MRNA SYNTHESIS & MODIFICATION SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 145
NORTH AMERICA: MRNA SYNTHESIS & MODIFICATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 146
EUROPE: MRNA SYNTHESIS & MODIFICATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 147
ASIA PACIFIC: MRNA SYNTHESIS & MODIFICATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 148
LATIN AMERICA: MRNA SYNTHESIS & MODIFICATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 149
MRNA PURIFICATION SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 150
NORTH AMERICA: MRNA PURIFICATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 151
EUROPE: MRNA PURIFICATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 152
ASIA PACIFIC: MRNA PURIFICATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 153
LATIN AMERICA: MRNA PURIFICATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 154
MRNA ANALYSIS & CHARACTERIZATION SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 155
NORTH AMERICA: MRNA ANALYSIS & CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 156
EUROPE: MRNA ANALYSIS & CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 157
ASIA PACIFIC: MRNA ANALYSIS & CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 158
LATIN AMERICA: MRNA ANALYSIS & CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 159
MANUFACTURING & SCALE-UP SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 160
NORTH AMERICA: MANUFACTURING & SCALE-UP SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 161
EUROPE: MANUFACTURING & SCALE-UP SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 162
ASIA PACIFIC: MANUFACTURING & SCALE-UP SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 163
LATIN AMERICA: MANUFACTURING & SCALE-UP SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 164
MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 165
MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 166
NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 167
EUROPE: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 168
ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 169
LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 170
MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 171
NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 172
EUROPE: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 173
ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 174
LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 175
MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR SMALL-SCALE CROS & CDMOS, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 176
NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR SMALL-SCALE CROS & CDMOS, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 177
EUROPE: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR SMALL-SCALE CROS & CDMOS, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 178
ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR SMALL-SCALE CROS & CDMOS, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 179
LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR SMALL-SCALE CROS & CDMOS, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 180
MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 181
MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 182
NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 183
NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 184
NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 185
NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 186
NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 187
NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 188
NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 189
NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 190
NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 191
NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 192
NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 193
MACROECONOMIC INDICATORS FOR NORTH AMERICA
 
 
 
 
TABLE 194
US: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 195
US: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 196
US: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 197
US: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 198
US: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 199
US: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 200
US: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 201
US: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 202
US: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 203
CANADA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 204
CANADA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 205
CANADA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 206
CANADA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 207
CANADA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 208
CANADA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 209
CANADA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 210
CANADA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 211
CANADA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 212
EUROPE: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 213
EUROPE: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 214
EUROPE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 215
EUROPE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 216
EUROPE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 217
EUROPE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 218
EUROPE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 219
EUROPE: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 220
EUROPE: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 221
EUROPE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 222
EUROPE: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 223
MACROECONOMIC INDICATORS FOR EUROPE
 
 
 
 
TABLE 224
GERMANY: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 225
GERMANY: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 226
GERMANY: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 227
GERMANY: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 228
GERMANY: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 229
GERMANY: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 230
GERMANY: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 231
GERMANY: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 232
GERMANY: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 233
UK: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 234
UK: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 235
UK: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 236
UK: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 237
UK: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 238
UK: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 239
UK: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 240
UK: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 241
UK: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 242
FRANCE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 243
FRANCE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 244
FRANCE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 245
FRANCE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 246
FRANCE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 247
FRANCE: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 248
FRANCE: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 249
FRANCE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 250
FRANCE: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 251
SWITZERLAND: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 252
SWITZERLAND: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 253
SWITZERLAND: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 254
SWITZERLAND: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 255
SWITZERLAND: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 256
SWITZERLAND: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 257
SWITZERLAND: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 258
SWITZERLAND: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 259
SWITZERLAND: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 260
ITALY: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 261
ITALY: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 262
ITALY: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 263
ITALY: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 264
ITALY: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 265
ITALY: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 266
ITALY: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 267
ITALY: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 268
ITALY: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 269
SPAIN: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 270
SPAIN: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 271
SPAIN: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 272
SPAIN: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 273
SPAIN: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 274
SPAIN: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 275
SPAIN: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 276
SPAIN: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 277
SPAIN: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 278
REST OF EUROPE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 279
REST OF EUROPE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 280
REST OF EUROPE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 281
REST OF EUROPE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 282
REST OF EUROPE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 283
REST OF EUROPE: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 284
REST OF EUROPE: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 285
REST OF EUROPE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 286
REST OF EUROPE: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 287
ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 288
ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 289
ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 290
ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 291
ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 292
ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 293
ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 294
ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 295
ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 296
ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 297
ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 298
MACROECONOMIC INDICATORS FOR ASIA PACIFIC
 
 
 
 
TABLE 299
CHINA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 300
CHINA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 301
CHINA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 302
CHINA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 303
CHINA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 304
CHINA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 305
CHINA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 306
CHINA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 307
CHINA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 308
JAPAN: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 309
JAPAN: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 310
JAPAN: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 311
JAPAN: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 312
JAPAN: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 313
JAPAN: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 314
JAPAN: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 315
JAPAN: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 316
JAPAN: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 317
INDIA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 318
INDIA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 319
INDIA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 320
INDIA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 321
INDIA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 322
INDIA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 323
INDIA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 324
INDIA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 325
INDIA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 326
SOUTH KOREA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 327
SOUTH KOREA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 328
SOUTH KOREA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 329
SOUTH KOREA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 330
SOUTH KOREA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 331
SOUTH KOREA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 332
SOUTH KOREA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 333
SOUTH KOREA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 334
SOUTH KOREA: MRNA SYNTHESIS AND MANUFACTURING SERVICE MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 335
REST OF ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 336
REST OF ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 337
REST OF ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 338
REST OF ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 339
REST OF ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 340
REST OF ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 341
REST OF ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 342
REST OF ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 343
REST OF ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 344
LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 345
LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 346
LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 347
LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 348
LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 349
LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 350
LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 351
LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 352
LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 353
LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 354
LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 355
MACROECONOMIC INDICATORS FOR LATIN AMERICA
 
 
 
 
TABLE 356
BRAZIL: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 357
BRAZIL: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 358
BRAZIL: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 359
BRAZIL: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 360
BRAZIL: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 361
BRAZIL: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 362
BRAZIL: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 363
BRAZIL: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 364
BRAZIL: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 365
REST OF LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 366
REST OF LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 367
REST OF LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 368
REST OF LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 369
REST OF LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 370
REST OF LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 371
REST OF LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 372
REST OF LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 373
REST OF LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 374
MIDDLE EAST: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 375
MIDDLE EAST: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 376
MIDDLE EAST: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 377
MIDDLE EAST: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 378
MIDDLE EAST: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 379
MIDDLE EAST: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 380
MIDDLE EAST: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 381
MIDDLE EAST: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 382
MIDDLE EAST: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 383
MACROECONOMIC INDICATORS FOR MIDDLE EAST
 
 
 
 
TABLE 384
AFRICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 385
AFRICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 386
AFRICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 387
AFRICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 388
AFRICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 389
AFRICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 390
AFRICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 391
AFRICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 392
AFRICA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 393
MACROECONOMIC INDICATORS FOR AFRICA
 
 
 
 
TABLE 406
THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 407
THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED
 
 
 
 
TABLE 408
THERMO FISHER SCIENTIFIC INC.: PRODUCT/SERVICE LAUNCHES, JANUARY 2021–JANUARY 2025
 
 
 
 
TABLE 409
THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021–JANUARY 2025
 
 
 
 
TABLE 410
THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2021–JANUARY 2025
 
 
 
 
TABLE 411
DANAHER CORPORATION: COMPANY OVERVIEW
 
 
 
 
TABLE 412
DANAHER CORPORATION: PRODUCTS/SERVICES OFFERED
 
 
 
 
TABLE 413
DANAHER CORPORATION: PRODUCT/SERVICE LAUNCHES, JANUARY 2021–JANUARY 2025
 
 
 
 
TABLE 414
DANAHER CORPORATION: DEALS, JANUARY 2021–JANUARY 2025
 
 
 
 
TABLE 415
DANAHER CORPORATION: EXPANSIONS, JANUARY 2021–JANUARY 2025
 
 
 
 
TABLE 416
MERCK KGAA: COMPANY OVERVIEW
 
 
 
 
TABLE 417
MERCK KGAA: PRODUCTS/SERVICES OFFERED
 
 
 
 
TABLE 418
MERCK KGAA: DEALS, JANUARY 2021–JANUARY 2025
 
 
 
 
TABLE 419
MERCK KGAA: EXPANSIONS, JANUARY 2021–JANUARY 2025
 
 
 
 
TABLE 420
LONZA: COMPANY OVERVIEW
 
 
 
 
TABLE 421
LONZA: PRODUCTS/SERVICES OFFERED
 
 
 
 
TABLE 422
LONZA: DEALS, JANUARY 2021–JANUARY 2025
 
 
 
 
TABLE 423
LONZA: EXPANSIONS, JANUARY 2021–JANUARY 2025
 
 
 
 
TABLE 424
MARVAI LIFESCIENCES: COMPANY OVERVIEW
 
 
 
 
TABLE 425
MARVAI LIFESCIENCES: PRODUCTS/SERVICES OFFERED
 
 
 
 
TABLE 426
MARVAI LIFESCIENCES: PRODUCT/SERVICE LAUNCHES, JANUARY 2021–JANUARY 2025
 
 
 
 
TABLE 427
MARVAI LIFESCIENCE: DEALS, JANUARY 2021–JANUARY 2025
 
 
 
 
TABLE 428
MARVAI LIFESCIENCES: EXPANSIONS, JANUARY 2021–JANUARY 2025
 
 
 
 
TABLE 429
GENSCRIPT: COMPANY OVERVIEW
 
 
 
 
TABLE 430
GENSCRIPT: PRODUCTS/SERVICES OFFERED
 
 
 
 
TABLE 431
GENSCRIPT: PRODUCT/SERVICE LAUNCHES, JANUARY 2021–JANUARY 2025
 
 
 
 
TABLE 432
GENSCRIPT: DEALS, JANUARY 2021– JANUARY 2025
 
 
 
 
TABLE 433
GENSCRIPT: EXPANSIONS, JANUARY 2021–JANUARY 2025
 
 
 
 
TABLE 434
NEW ENGLAND BIOLABS: COMPANY OVERVIEW
 
 
 
 
TABLE 435
NEW ENGLAND BIOLABS: PRODUCTS/SERVICES OFFERED
 
 
 
 
TABLE 436
NEW ENGLAND BIOLABS: PRODUCT/SERVICE LAUNCHES, JANUARY 2021–JANUARY 2025
 
 
 
 
TABLE 437
PROMEGA CORPORATION: COMPANY OVERVIEW
 
 
 
 
TABLE 438
PROMEGA CORPORATION: PRODUCTS/SERVICES OFFERED
 
 
 
 
TABLE 439
PROMEGA CORPORATION: EXPANSIONS, JANUARY 2021–JANUARY 2025
 
 
 
 
TABLE 440
PROMEGA CORPORATION: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025
 
 
 
 
TABLE 441
WUXI BIOLOGICS: COMPANY OVERVIEW
 
 
 
 
TABLE 442
WUXI BIOLOGICS: PRODUCTS/SERVICES OFFERED
 
 
 
 
TABLE 443
WUXI BIOLOGICS: EXPANSIONS, JANUARY 2021–JANUARY 2025
 
 
 
 
TABLE 444
TAKARA BIO INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 445
TAKARA BIO INC.: PRODUCTS/SERVICES OFFERED
 
 
 
 
TABLE 446
TAKARA BIO INC.: PRODUCT/SERVICE LAUNCHES, JANUARY 2021–JANUARY 2025
 
 
 
 
TABLE 447
TAKARA BIO INC.: DEALS, JANUARY 2021–JANUARY 2025
 
 
 
 
TABLE 448
SARTORIUS AG: COMPANY OVERVIEW
 
 
 
 
TABLE 449
SARTORIUS AG: PRODUCTS/SERVICES OFFERED
 
 
 
 
TABLE 450
SARTORIUS AG: DEALS, JANUARY 2021–JANUARY 2025
 
 
 
 
TABLE 451
AZENTA US INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 452
AZENTA US INC.: PRODUCTS/SERVICES OFFERED
 
 
 
 
TABLE 453
TELESIS BIO INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 454
TELESIS BIO INC.: PRODUCTS/SERVICES OFFERED
 
 
 
 
TABLE 455
TELESIS BIO INC.: PRODUCT/SERVICE LAUNCHES, JANUARY 2021–JANUARY 2025
 
 
 
 
TABLE 456
TELESIS BIO INC.: DEALS, JANUARY 2021–JANUARY 2025
 
 
 
 
TABLE 457
ST PHARM: COMPANY OVERVIEW
 
 
 
 
TABLE 458
ST PHARM: PRODUCTS/SERVICES OFFERED
 
 
 
 
TABLE 459
ST PHARM: DEALS, JANUARY 2021–JANUARY 2025
 
 
 
 
TABLE 460
AGC INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 461
AGC INC.: PRODUCTS/SERVICES OFFERED
 
 
 
 
TABLE 462
AGC INC.: DEALS, JANUARY 2021–JANUARY 2025
 
 
 
 
TABLE 463
AGC INC.: EXPANSIONS, JANUARY 2021–JANUARY 2025
 
 
 
 
TABLE 464
DR. REDDY’S LABORATORIES LTD.: COMPANY OVERVIEW
 
 
 
 
TABLE 465
DR. REDDY’S LABORATORIES LTD.: PRODUCTS/SERVICES OFFERED
 
 
 
 
TABLE 466
DR. REDDY’S LABORATORIES LTD.: EXPANSIONS, JANUARY 2021–JANUARY 2025
 
 
 
 
TABLE 467
ETHERNA: COMPANY OVERVIEW
 
 
 
 
TABLE 468
BOC SCIENCES: COMPANY OVERVIEW
 
 
 
 
TABLE 469
BIOMAY AG: COMPANY OVERVIEW
 
 
 
 
TABLE 470
CURIA GLOBAL, INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 471
JENA BIOSCIENCE GMBH: COMPANY OVERVIEW
 
 
 
 
TABLE 472
ENZYNOMICS CO., LTD.: COMPANY OVERVIEW
 
 
 
 
TABLE 473
KANEKA EUROGENTEC S.A.: COMPANY OVERVIEW
 
 
 
 
TABLE 474
VERNAL BIOSCIENCES: COMPANY OVERVIEW
 
 
 
 
TABLE 475
CELLSCRIPT: COMPANY OVERVIEW
 
 
 
 
LIST OF FIGURES
 
 
 
 
 
FIGURE 1
MRNA SYNTHESIS & MANUFACTURING MARKET SEGMENTATION AND REGIONAL SCOPE
 
 
 
 
FIGURE 2
MRNA SYNTHESIS & MANUFACTURING MARKET: RESEARCH DESIGN
 
 
 
 
FIGURE 3
BREAKDOWN OF PRIMARY INTERVIEWS: BY RESPONDENT, DESIGNATION, AND REGION
 
 
 
 
FIGURE 4
MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023
 
 
 
 
FIGURE 5
MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023
 
 
 
 
FIGURE 6
MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION FOR PRODUCT MARKET), 2023
 
 
 
 
FIGURE 7
MARKET SIZE ESTIMATION: APPROACH 2 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION FOR SERVICE MARKET), 2023
 
 
 
 
FIGURE 8
ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC, INC.: REVENUE SHARE ANALYSIS, 2023
 
 
 
 
FIGURE 9
MARKET SIZE VALIDATION FROM PRIMARY SOURCES
 
 
 
 
FIGURE 10
MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
 
 
 
 
FIGURE 11
MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET: CAGR PROJECTIONS, 2024–2029
 
 
 
 
FIGURE 12
MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET: CAGR PROJECTIONS, 2024–2029
 
 
 
 
FIGURE 13
MRNA SYNTHESIS & MANUFACTURING MARKET: DATA TRIANGULATION METHODOLOGY
 
 
 
 
FIGURE 14
MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
 
 
 
 
FIGURE 15
MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2024 VS. 2029 (USD MILLION)
 
 
 
 
FIGURE 16
MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
 
 
 
 
FIGURE 17
MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
 
 
 
 
FIGURE 18
MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
 
 
 
 
FIGURE 19
MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET: GEOGRAPHICAL SNAPSHOT
 
 
 
 
FIGURE 20
EXPANDING APPLICATIONS OF MRNA TECHNOLOGY TO DRIVE MARKET
 
 
 
 
FIGURE 21
CONSUMABLES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
 
 
 
 
FIGURE 22
MRNA SYNTHESIS & MODIFICATION TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
 
 
 
 
FIGURE 23
MRNA SYNTHESIS & MANUFACTURING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
 
 
 
 
FIGURE 24
REVENUE SHIFT AND NEW REVENUE POCKETS FOR PLAYERS IN MRNA SYNTHESIS & MANUFACTURING MARKET
 
 
 
 
FIGURE 25
MRNA SYNTHESIS & MANUFACTURING MARKET: VALUE CHAIN ANALYSIS
 
 
 
 
FIGURE 26
AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY INSTRUMENT, 2021–2023 (USD)
 
 
 
 
FIGURE 27
AVERAGE SELLING PRICE TREND, BY CONSUMABLE, 2021–2023 (USD)
 
 
 
 
FIGURE 28
AVERAGE SELLING PRICE, BY REGION, 2023 (USD)
 
 
 
 
FIGURE 29
MRNA SYNTHESIS & MANUFACTURING MARKET: PATENT ANALYSIS, 2014–2024
 
 
 
 
FIGURE 30
MRNA SYNTHESIS & MANUFACTURING MARKET: SUPPLY CHAIN ANALYSIS
 
 
 
 
FIGURE 31
MRNA SYNTHESIS & MANUFACTURING MARKET: ECOSYSTEM ANALYSIS
 
 
 
 
FIGURE 32
MRNA SYNTHESIS & MANUFACTURING MARKET: PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
FIGURE 33
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING
 
 
 
 
FIGURE 34
KEY BUYING CRITERIA, BY END USER (PRODUCT)
 
 
 
 
FIGURE 35
RESEARCH FUNDING FOR MRNA SYNTHESIS & MANUFACTURING BY INSTITUTES AND CENTERS, 2021–2024 (USD MILLION)
 
 
 
 
FIGURE 36
IMPACT OF AI ON MRNA SYNTHESIS & MANUFACTURING MARKET
 
 
 
 
FIGURE 37
MRNA SYNTHESIS & MANUFACTURING INSTRUMENTS MARKET, BY VOLUME, 2022–2029
 
 
 
 
FIGURE 38
NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET SNAPSHOT
 
 
 
 
FIGURE 39
ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET SNAPSHOT
 
 
 
 
FIGURE 48
THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023)
 
 
 
 
FIGURE 49
DANAHER CORPORATION: COMPANY SNAPSHOT (2023)
 
 
 
 
FIGURE 50
MERCK KGAA: COMPANY SNAPSHOT (2023)
 
 
 
 
FIGURE 51
LONZA: COMPANY SNAPSHOT (2023)
 
 
 
 
FIGURE 52
MARVAI LIFESCIENCES: COMPANY SNAPSHOT (2023)
 
 
 
 
FIGURE 53
GENSCRIPT: COMPANY SNAPSHOT (2023)
 
 
 
 
FIGURE 54
WUXI BIOLOGICS: COMPANY SNAPSHOT (2023)
 
 
 
 
FIGURE 55
TAKARA BIO INC.: COMPANY SNAPSHOT (2023)
 
 
 
 
FIGURE 56
SARTORIUS AG: COMPANY SNAPSHOT (2023)
 
 
 
 
FIGURE 57
AZENTA US INC.: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 58
TELESIS BIO INC.: COMPANY SNAPSHOT (2023)
 
 
 
 
FIGURE 59
ST PHARM: COMPANY SNAPSHOT (2023)
 
 
 
 
FIGURE 60
AGC INC.: COMPANY SNAPSHOT (2023)
 
 
 
 
FIGURE 61
DR. REDDY’S LABORATORIES LTD.: COMPANY SNAPSHOT (2023)
 
 
 
 

Methodology

The study involved major activities in estimating the current market size for the mRNA synthesis and manufacturing market. Exhaustive secondary research was done to collect information on the mRNA synthesis and manufacturing industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as market share analysis, MnM repository analysis, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the mRNA synthesis and manufacturing market.

Secondary Research

The market for the companies offering mRNA synthesis and manufacturing solutions is arrived at by secondary data available through paid and unpaid sources, analyzing the product & service portfolios of the major companies in the ecosystem, and rating the companies by their performance and quality. Various sources were referred to in the secondary research process to identify and collect information for this study. The secondary sources include annual reports, press releases, investor presentations of companies, white papers, journals, certified publications, and articles from recognized authors, directories, and databases. In the secondary research process, various secondary sources were referred to for identifying and collecting information related to the study. Secondary sources included annual reports, press releases, and investor presentations of blockchain vendors, forums, certified publications, and whitepapers. The secondary research was used to obtain critical information on the industry’s value chain, the total pool of key players, market classification, and segmentation from the market and product-oriented perspectives.

Primary Research

Extensive primary research was conducted after acquiring basic knowledge about the global mRNA synthesis and manufacturing market scenario. Several primary interviews were conducted with market experts from both the demand side (such as personnel from the pharmaceutical & biopharmaceutical industry) and the supply side (such as C-level and D-level executives, product managers, marketing and sales managers of key manufacturers, distributors, as well as channels) across five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. Approximately 80% and 20% of primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, and online, personal, and telephonic interviews.

The following is a breakdown of the primary respondents:

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Top-down approache was used to estimate and validate the total size of the mRNA synthesis and manufacturing market. These methods include market share analysis, MnM repository analysis were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and market have been identified through extensive secondary research.
  • The revenues generated from the mRNA synthesis and manufacturing market business of leading players have been determined through primary and secondary research.
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments.

Data Triangulation

After arriving at the market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable.

Market Definition

mRNA synthesis and manufacturing refers to the process of producing messenger RNA (mRNA) through in vitro transcription, followed by various purification, and characterization steps to create high-quality mRNA products suitable for research, therapeutic, or vaccine applications. The mRNA synthesis and manufacturing market encompasses the development, production, and commercialization of messenger RNA (mRNA) products, including their synthesis via in vitro transcription, large-scale manufacturing, and formulation. This market serves various applications such as vaccines, therapeutic treatments, and potentially other areas like protein replacement. It involves specialized technologies and equipment, adherence to regulatory standards, and a global supply chain network.

The study provides an in-depth analysis of the mRNA synthesis and manufacturing market based on contemporary market trends and developments, and its potential growth from 2024 to 2029. It includes detailed market trends, the competitive landscape, market size, forecasts, and the analysis of the key mRNA synthesis and manufacturing product and service providers.

Stakeholders

  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Contract Development and Manufacturing Organizations (CDMOs)
  • Raw Material Suppliers
  • Market Research and Consulting Firms
  • Regulatory Agencies
  • Venture Capitalists
  • Government Organizations
  • Industry Associations and Professional Societies

Report Objectives

  • To define, describe, and forecast the mRNA synthesis and manufacturing market based on product, service, application, and region
  • To define, describe, and forecast the mRNA synthesis and manufacturing market based on product by end user and service by end user
  • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the mRNA synthesis and manufacturing market
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to six main regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
  • To profile the key players in the global mRNA synthesis and manufacturing market and comprehensively analyze their products and services portfolios, market positions, and core competencies.
  • To track and analyze competitive developments such as product/service launches, expansions, agreements, and collaborations in the mRNA synthesis and manufacturing market
  • To benchmark players within the mRNA synthesis and manufacturing market using the Company Evaluation Matrix framework, which analyzes market players based on various parameters within the broad categories of business and service strategy

Key Questions Addressed by the Report

Who are the key players in the mRNA synthesis and manufacturing market?

Key players in the global mRNA synthesis and manufacturing market include Merck KGaA (Germany), Thermo Fisher Scientific Inc. (US), GenScript (US), New England Biolabs (US), AldevronLLC. (US), Promega Corporation (US), Sartorius AG (Germany), WuXi Biologics (China), Takara Bio Inc. (Japan), GENEWIZ (US), TriLink BioTechnologies (US), Lonza (Switzerland), Telesis Bio Inc. (US), and Aurigene Pharmaceutical Services Ltd. (India).

Which product dominates the mRNA synthesis and manufacturing market?

The consumables segment dominated the mRNA synthesis and manufacturing market in 2023.

Which application segment of the global mRNA synthesis and manufacturing market is expected to witness the highest growth?

The cell and gene therapy segment is expected to witness the highest growth in the forecast period. This is attributed to the increasing demand for personalized therapies and is supported by regulatory approvals and a large clinical pipeline.

What is the size of the mRNA synthesis and manufacturing market?

The mRNA synthesis and manufacturing market is estimated to account for USD 624.4 million in 2024.

What is the growth rate of the mRNA synthesis and manufacturing market?

The global mRNA synthesis and manufacturing market is expected to grow at 3.4% CAGR during the forecast period of 2024-2029.

TABLE OF CONTENTS

METHODOLOGY

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the mRNA Synthesis & Manufacturing Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request
Forbes

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in mRNA Synthesis & Manufacturing Market

DMCA.com Protection Status